Data demonstrating decisiondx®-melanoma's ability to risk-stratify patients according to melanoma-specific survival to be shared during the 2022 asco annual meeting

Friendswood, texas--(business wire)---- $cstl #cstl--castle announced that an abstract regarding its decisiondx®-melanoma test will be available online during the upcoming 2022 asco annual meeting.

CSTL Ratings Summary

CSTL Quant Ranking